New study: drug lowers heart attack risk 20% beyond statins

A clinical study reports a 20% reduction in heart attack risk with a non-statin cholesterol drug, addressing a key question for patients who do not respond adequately to statins. The finding is preliminary and not yet fully detailed, but could shift treatment guidelines if corroborated.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works